Home » Topics » Regulatory

Regulatory
RSS

Paroxetine approved for new indication

May 17, 1996

Supplemental NDA filed for Novantrone in U.S.

May 17, 1996

UNAIDS initiates clinical program to evaluate Advantage 24 in STD transmission

May 17, 1996

Advisory committee refuses to recommend Coreg approval for CHF

May 10, 1996

Zynaxis to develop Zyn-Linker form of paclitaxel for restenosis Rx

May 10, 1996

Napp introduces novel diltiazem formulation in U.K.

May 10, 1996

New pediatric approval for Zofran in U.K.

May 10, 1996

Saquinavir combinations under clinical evaluation

May 10, 1996

Supplemental NDA filing for Abelcet

May 10, 1996

SKB's intranasal mupirocin now available in U.S.

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 6, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 6, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.